Pulling SEC filings + quote and writing the call…

Amesite Inc.
Next earnings Sep 28, 2026
Revenue fell -33.8% YoY.
Amesite Inc. shows $110K in FY2025 revenue (-33.8% YoY), a -3274.6% net margin, and -132.1% ROE.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $675K | $697K | $845K | $167K | $110K |
| Gross profit | — | — | — | — | — |
| Operating income | — | -$9.06M | -$4.22M | -$4.58M | -$3.60M |
| Net income | -$11.6M | -$9.06M | -$4.15M | -$4.40M | -$3.62M |
| Diluted EPS | -$0.59 | -$4.67 | -$1.68 | -$1.73 | -$1.03 |
| Net margin | -1717.6% | -1299.8% | -491.5% | -2638.5% | -3274.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001807166, latest 10-Q filed 2026-05-18) · EODHD · as of 6/22/2026, 11:29:39 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 2 open-market buys · 0 sales
| 2026-04-28 | Sastry Ann Marie CHIEF EXECUTIVE OFFICER | Buy | 174K @ $1.44 | $250K |
| 2026-04-28 | Parmer George Director | Buy | 244K @ $1.44 | $350K |
| 2026-03-07 | Parmer George Director | Exercise | 41.3K | |
| 2026-03-07 | Brewer Barbie Director | Exercise | 41.3K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.